Latest
Daratumumab Plus Pomalidomide and Dexamethasone Improved PFS in Rel/Ref Multiple Myeloma
Risk Factors Identified for All-Cause Mortality in Cancer Patients With COVID-19
Anemia May Increase Risks of Ischemic Stroke and Poststroke Mortality
Diagnostic Features of Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Older Patients With NHL at High Risk for Treatment-Related Toxicity Events
HDMTX Promising for Patients With Primary CNS Lymphoma Ineligible for Clinical Trials
LRPAP1 Autoantibodies Have Prognostic Value in Mantle Cell Lymphoma
Dose/Schedule-Adjusted Lenalidomide-Dexamethasone Shows Positive Survival Outcomes in Multiple Myeloma
FDA Issues Safety Alert Regarding Use of Hydroxyethyl Starch Products
Blood Shortage Causes Surgery Delays in New England
Carfilzomib Therapies Effective for Patients With Relapsed/Refractory Multiple Myeloma
Baseline Blood Counts Best Predictor of Response in Severe Aplastic Anemia
Featured Content
-
ASCO 2021 Coverage
Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. -
Treatment Challenges in Mild-To-Moderate Hemophilia
Researchers worked to better understand and manage patients with mild or moderate hemophilia, who can be an underrepresented and underserved population. -
Current State of Combination Therapy for Checkpoint Inhibitors
Despite the clinical success of combination therapy with immune checkpoint inhibitors many research questions still remain. -
NCCN Guidelines for Multiple Myeloma Updated to Include Three Selinexor Regimens
The National Comprehensive Cancer Network’s updated Clinical Practice Guidelines in Oncology for multiple myeloma newly include 3 new selinexor-containing regimens. -
Telemedicine for Hematology During COVID-19 and Beyond
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices. -
Mild to Moderate Hemophilia: Experts Discuss Challenges and Propose Solutions
A group of US-based hemophilia experts summarized unmet needs in mild to moderate hemophilia and provided suggestions for healthcare professionals to optimally manage their patients with this challenging condition. -
American Society of Hematology Releases Updated Guidelines for Treating Newly Diagnosed AML in Older Adults
This review of the guidelines is presented as 6 questions and answers that help direct treatment decision for patients 65 and older with newly diagnosed AML.
- Loading...
Loading...
Loading... 
Loading...